Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1766431

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1766431

China Drug Delivery Devices Market Outlook to 2033 - Central Venous Catheters, Implantable Ports and Infusion Systems

PUBLISHED:
PAGES: 89 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 5995
PDF (Site License)
USD 11990
PDF (Global License)
USD 17985

Add to Cart

China Drug Delivery Devices Market Outlook to 2033 - Central Venous Catheters , Implantable Ports and Infusion Systems

GlobalData's "China Drug Delivery Devices Market Outlook to 2033" is a comprehensive databook report, covering key market data on the China Drug Delivery Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market categories - Infusion Systems, Central Venous Catheters and Implantable Ports

The China Drug Delivery Devices Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market categories. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Drug Delivery Devices Market.
  • Global corporate-level profiles of key companies operating within the China Drug Delivery Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

China Drug Delivery Devices is segmented as follows -

  • Infusion Systems
  • Central Venous Catheters
  • Implantable Ports

Reasons to Buy

The China Drug Delivery Devices Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME0626MDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Drug Delivery Devices Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Drug Delivery Devices Market, China

  • 3.1 Drug Delivery Devices Market, China, Revenue ($m), 2018-2033
  • 3.2 Drug Delivery Devices Market, China, Revenue Mix ($m), 2023
  • 3.3 Drug Delivery Devices Market, China, Category Contribution by Revenue ($m), 2023
  • 3.4 Drug Delivery Devices Market, China, Revenue ($m), 2018-2033
  • 3.5 Drug Delivery Devices Market, China, Volume (Units), 2018-2033
  • 3.6 Drug Delivery Devices Market, China, Volume (Units), 2018-2033
  • 3.7 Drug Delivery Devices Market, China, Company Share by Revenue ($m), 2023

4 Central Venous Catheters Market, China

  • 4.1 Central Venous Catheters Market, China, Revenue Mix ($m), 2023
  • 4.2 Central Venous Catheters Market, China, Segment Contribution (%), 2023
  • 4.3 Central Venous Catheters Market, China, Revenue ($m), 2018-2033
  • 4.4 Central Venous Catheters Market, China, Volume (Units), 2018-2033
  • 4.6 Central Venous Catheters Market, China, Average Price ($) , 2018-2033
  • 4.7 Central Venous Catheters Market, China, Distribution Share by Revenue ($m), 2023
  • 4.8 Central Venous Catheters Market, China, Company Share by Revenue ($m), 2023

5 Implantable Ports Market, China

  • 5.1 Implantable Ports Market, China, Revenue Mix ($m), 2023
  • 5.2 Implantable Ports Market, China, Segment Contribution (%), 2023
  • 5.3 Implantable Ports Market, China, Revenue ($m), 2018-2033
  • 5.4 Implantable Ports Market, China, Volume (Units), 2018-2033
  • 5.5 Implantable Ports Market, China, Average Price ($) , 2018-2033
  • 5.6 Implantable Ports Market, China, Distribution Share by Revenue ($m), 2023
  • 5.7 Implantable Ports Market, China, Company Share by Revenue ($m), 2023

6 Infusion Systems Market, China

  • 6.1 Infusion Systems Market, China, Revenue Mix ($m), 2023
  • 6.2 Infusion Systems Market, China, Segment Contribution (%), 2023
  • 6.3 Infusion Systems Market, China, Revenue ($m), 2018-2033
    • 6.3.1 Infusion Pump Disposables Market, China, Revenue ($m), by Segment, 2018-2033
    • 6.3.2 Infusion Pumps Market, China, Revenue ($m), by Segment, 2018-2033
  • 6.4 Infusion Systems Market, China, Volume (Units), 2018-2033
    • 6.4.1 Infusion Pump Disposables Market, China, Volume (Units), by Segment, 2018-2033
    • 6.4.2 Infusion Pumps Market, China, Volume (Units), by Segment, 2018-2033
  • 6.5 Infusion Systems Market, China, Average Price ($) , 2018-2033
  • 6.6 Infusion Systems Market, China, Distribution Share by Revenue ($m), 2023
  • 6.7 Infusion Systems Market, China, Company Share by Revenue ($m), 2023

7 Overview of Key Companies in China, Drug Delivery Devices Market

  • 7.1 Becton Dickinson and Co
    • 7.1.1 Company Overview
  • 7.2 B. Braun Melsungen AG
    • 7.2.1 Company Overview
  • 7.3 Baxter International Inc
    • 7.3.1 Company Overview
  • 7.4 Teleflex Inc
    • 7.4.1 Company Overview

8 Drug Delivery Devices Market Pipeline Products

9 Financial Deals Landscape

  • 9.1 Acquisition
    • 9.1.1 Otsuka Holdings May Sell Stake in MicroPort Scientific
    • 9.1.2 Sunshine Lake Pharma to Acquire Yichang Hec Changjiang Pharma
  • 9.2 Equity Offerings
    • 9.2.1 Lvkang Biochemical to Raise USD11 Million in Public Offering of Shares
  • 9.3 Venture Financing
    • 9.3.1 Changzhou Taimeirui Biotechnology Secures USD1.415 Million in Angel Funding
    • 9.3.2 Zhejiang Haigetang Pharma Secures Series A Financing
    • 9.3.3 Shanghai Injexin Medical Technology Raises Funds through Series A Financing
    • 9.3.4 Guangzhou Aidi Gene Technology (Eddie Gene, Aidigene) Raises Approximately USD1.39 Million in Angel Financing
    • 9.3.5 Suzhou Hanerxi Medical Device Development (Hanxi Medical) Raises Funds through Series B Financing

10 Recent Developments

  • 10.1 Corporate Communications
    • 10.1.1 May 07, 2024: Yichang Hec Changjiang Pharmaceutical Notice of Annual General Meeting
  • 10.2 Financial Announcements
    • 10.2.1 Aug 14, 2024: Solasia Pharma Reports Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2024
    • 10.2.2 Aug 14, 2024: Glenmark Pharma Reports Consolidated Revenue Growth of 6.9%, EBITDA Margin of 18.1% and PAT Margin of 10.5% YoY for Q1 FY 2024-25
    • 10.2.3 Aug 12, 2024: Clearside Biomedical Announces Second Quarter 2024 Financial Results and Provides Corporate Update
    • 10.2.4 Aug 06, 2024: Cellectis Provides Financial Results for the Second Quarter 2024
  • 10.3 Government and Public Interest
    • 10.3.1 Jun 13, 2024: Direct Delivery of Oligonucleotide Drugs to the CNS and Common Histopathological Changes
  • 10.4 Legal And Regulatory
    • 10.4.1 Apr 15, 2025: Hangzhou SHINING3D Dental Technology Receives 510(K) Clearance For DT20 Denture Base Resin
    • 10.4.2 May 29, 2024: Gan & Lee Pharmaceuticals Pass the EMA Pre-Approval (GMP) Inspection
  • 10.5 Other Significant Developments
    • 10.5.1 Apr 23, 2025: Nanologica Receives Order Worth USD 180,000 from New Customer in China
    • 10.5.2 Dec 03, 2024: Nanologica Receives Order on Nlab Saga Valued at Approx Sek 1,9 Million
  • 10.6 Product News
    • 10.6.1 Aug 01, 2024: Nonclinical Safety Evaluation Of Ocular Drug Delivery Using Cynomolgus Macaques
    • 10.6.2 Aug 01, 2024: Advancing CNS And CGT Research: Prisys Biotechnologies Leading The Way
    • 10.6.3 Jun 13, 2024: Direct Delivery Of the Oligonucleotide Drugs To The CNS And Common Histopathological Changes

11 Appendix

  • 11.1 Research Methodology
    • 11.1.1 Coverage
    • 11.1.2 Secondary Research
    • 11.1.3 Primary Research
    • 11.1.4 Market Modeling and Forecasting
    • 11.1.5 Company Share Analysis
    • 11.1.6 Distribution Share Analysis
    • 11.1.7 Benchmarking
  • 11.2 GlobalData Consulting
  • 11.3 Contact Us
  • 11.4 Disclaimer
Product Code: GDME0626MDB

List of Table

List of Tables

  • Table 1: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 2: Drug Delivery Devices Market, China, Category Contribution by Revenue ($m), 2023
  • Table 3: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 4: Drug Delivery Devices Market, China, Volume (Units), 2018-2033
  • Table 5: Drug Delivery Devices Market, China, Volume (Units), 2018-2033
  • Table 6: Drug Delivery Devices Market, China, Company Share by Revenue ($m), USD Constant, 2023
  • Table 7: Central Venous Catheters Market, China, Segment Contribution (%), 2023
  • Table 8: Central Venous Catheters Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 9: Central Venous Catheters Market, China, Volume (Units), 2018-2033
  • Table 10: Central Venous Catheters Market, China, Average Price ($), 2018-2033
  • Table 11: Central Venous Catheters Market, China, Distribution Share by Revenue ($m), USD Constant, 2023
  • Table 12: Central Venous Catheters Market, China, Company Share by Revenue ($m), USD Constant, 2023
  • Table 13: Implantable Ports Market, China, Segment Contribution (%), 2023
  • Table 14: Implantable Ports Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 15: Implantable Ports Market, China, Volume (Units), 2018-2033
  • Table 16: Implantable Ports Market, China, Average Price ($), 2018-2033
  • Table 17: Implantable Ports Market, China, Distribution Share by Revenue ($m), USD Constant, 2023
  • Table 18: Implantable Ports Market, China, Company Share by Revenue ($m), USD Constant, 2023
  • Table 19: Infusion Systems Market, China, Segment Contribution (%), 2023
  • Table 20: Infusion Systems Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 21: Infusion Pump Disposables Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 22: Infusion Pumps Market, China, Revenue ($m), USD Constant, 2018-2033
  • Table 23: Infusion Systems Market, China, Volume (Units), 2018-2033
  • Table 24: Infusion Pump Disposables Market, China, Volume (Units), 2018-2033
  • Table 25: Infusion Pumps Market, China, Volume (Units), 2018-2033
  • Table 26: Infusion Systems Market, China, Average Price ($), 2018-2033
  • Table 27: Infusion Systems Market, China, Distribution Share by Revenue ($m), USD Constant, 2023
  • Table 28: Infusion Systems Market, China, Company Share by Revenue ($m), USD Constant, 2023
  • Table 29: Drug Delivery Devices Market Pipeline Products
  • Table 30: Otsuka Holdings May Sell Stake in MicroPort Scientific
  • Table 31: Sunshine Lake Pharma to Acquire Yichang Hec Changjiang Pharma
  • Table 32: Lvkang Biochemical to Raise USD11 Million in Public Offering of Shares
  • Table 33: Changzhou Taimeirui Biotechnology Secures USD1.415 Million in Angel Funding
  • Table 34: Zhejiang Haigetang Pharma Secures Series A Financing
  • Table 35: Shanghai Injexin Medical Technology Raises Funds through Series A Financing
  • Table 36: Guangzhou Aidi Gene Technology (Eddie Gene, Aidigene) Raises Approximately USD1.39 Million in Angel Financing
  • Table 37: Suzhou Hanerxi Medical Device Development (Hanxi Medical) Raises Funds through Series B Financing
  • Table 38: Total Number of Primary Research Participants, Drug Delivery Devices Market, by Country

List of Figure

List of Figures

  • Figure 1: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: Drug Delivery Devices Market, China, Revenue Mix ($m), 2023
  • Figure 3: Drug Delivery Devices Market, China, Category Contribution (%), 2023
  • Figure 4: Drug Delivery Devices Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 5: Drug Delivery Devices Market, China, Volume (Units), 2018-2033
  • Figure 6: Drug Delivery Devices Market, China, Volume (Units), 2018-2033
  • Figure 7: Drug Delivery Devices Market, China, Company Share (%) 2023
  • Figure 8: Central Venous Catheters Market, China, Revenue Mix ($m), 2023
  • Figure 9: Central Venous Catheters Market, China, Segment Contribution (%), 2023
  • Figure 10: Central Venous Catheters Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 11: Central Venous Catheters Market, China, Volume (Units), 2018-2033
  • Figure 12: Central Venous Catheters Market, China, Company Share (%) 2023
  • Figure 13: Implantable Ports Market, China, Revenue Mix ($m), 2023
  • Figure 14: Implantable Ports Market, China, Segment Contribution (%), 2023
  • Figure 15: Implantable Ports Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 16: Implantable Ports Market, China, Volume (Units), 2018-2033
  • Figure 17: Implantable Ports Market, China, Company Share (%) 2023
  • Figure 18: Infusion Systems Market, China, Revenue Mix ($m), 2023
  • Figure 19: Infusion Systems Market, China, Segment Contribution (%), 2023
  • Figure 20: Infusion Systems Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 21: Infusion Pump Disposables Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 22: Infusion Pumps Market, China, Revenue ($m), USD Constant, 2018-2033
  • Figure 23: Infusion Systems Market, China, Volume (Units), 2018-2033
  • Figure 24: Infusion Pump Disposables Market, China, Volume (Units), 2018-2033
  • Figure 25: Infusion Pumps Market, China, Volume (Units), 2018-2033
  • Figure 26: Infusion Systems Market, China, Company Share (%) 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!